Abstract:Zhongqi Sun, 1 Xin Li, 1 Hongwei Liang, 1 Zhongxing Shi, 2 Hongjia Ren 3 1 Department of Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, People's Republic of China; 2 Department of Interventional Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, People's Republic of China; 3 School of Information Science and Engineering, Yanshan University, Qinhuangdao, 066004, People's Republic of China Correspondence: Zhongqi Sun, Email ; Hongjia Ren, Email Background: To develop and validate an overall survival (OS) prediction model for transarterial chemoembolization (TACE). Methods: In this retrospective study, 301 patients with hepatocellular carcinoma (HCC) who received TACE from 2012 to 2015 were collected. The residual network was used to extract prognostic information from CT images, which was then combined with the clinical factors adjusted by COX regression to predict survival using a modified deep learning model (DLOP Combin ). The DLOP Combin model was compared with the residual network model (DLOP CTR ), multiple COX regression model (DLOP Cox ), Radiomic model (Radiomic), and clinical model. Results: In the validation cohort, DLOP Combin shows the highest TD AUC of all cohorts, which compared with Radiomic (TD AUC: 0.96vs 0.63) and clinical model (TD AUC: 0.96 vs 0.62) model. DLOP Combin showed significant difference in C index compared with DLOP CTR and DLOP Cox models ( P < 0.05). Moreover, the DLOP Combin showed good calibration and overall net benefit. Patients with DLOP Combin model score ≤ 0.902 had better OS (33 months vs 15.5 months, P < 0.0001). Conclusion: The deep learning model can effectively predict the patients' overall survival of TACE. Keywords: deep learning, transarterial chemoembolization, hepatocellular carcinoma Liver cancer is the third leading cause of cancer-related deaths worldwide. 1,2 Hepatocellular carcinoma (HCC) is the most common type of liver cancer. 3 Patients with early HCC are therapeutic with transplantation, resection, and ablation, and have an overall 5-year survival rate reaching 70–80%. 4 However, approximately 80% of patients are in the Barcelona Clinic Liver Cancer staging classification B (BCLC B) at the time of diagnosis, with significantly decreased survival. 5 Currently, transcatheter arterial chemoembolization (TACE) is the first-line therapy for patients in BCLC B stage. 6 Nevertheless, the objective response rate for TACE was 52.5% and the 3-year overall survival (OS) was 40.4%. 7 Accordingly, understanding the prognosis of TACE patients and predicting the survival period of TACE patients is crucial in the overall treatment, which can stratify the risk of diseases and help clinicians to make more personalized decisions, such as determining the follow-up time and planning the treatment programme. Previous studies have suggested several clinical factors are associated with the prognosis of TACE, including tumor size, tumor numbers, and alpha-fetoprotein (AFP) levels. 8–10 Moreover, relevant researchers have developed scoring systems that integrate various clinical information, such as the BCLC B subclassification, albumin-bilirubin (ALBI) grade, and neutrophil-to-lymphocyte ratio. 11–13 The above methods can assist clinicians in predicting survival to some extent, whereas, they implicitly assume that the relationship between predictor variables and output results is linear, which may not be a valid assumption, and few studies incorporate radiomic information. CT examination contains not only tumor size and imaging features, but also more information about the prognosis of the primary tumor. 14,15 Studies have shown that illustrates that the imaging phenotype at the macro level is closely related to the tissue phenotype at the micro level, and even closely related to molecular pathways and genetic changes. 16,17 Obviously, high-dimensional information mined from CT can be used to predict the survival of TACE patients. In recent years, image-based deep learning methods have shown promising potential for predicting survival, it constructs a model with a large number of hidden layers, automatically extract features, and find various complex nonlinear relationships between input and output after repeated correction. 18,19 Therefore, deep learning can be used to predict the survival problem of TACE based on CT images. 20 However, in these studies, the prediction model did not account for im -Abstract Truncated-

Multi-Task Deep Learning Approach for Simultaneous Objective Response Prediction and Tumor Segmentation in HCC Patients with Transarterial Chemoembolization

Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging

Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos

Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma

Prediction of microvascular invasion and pathological differentiation of hepatocellular carcinoma based on a deep learning model

Prediction of TACE Treatment Response in a Preoperative MRI via Analysis of Integrating Deep Learning and Radiomics Features

Prediction of Therapeutic Response to Transarterial Chemoembolization Plus Systemic Therapy Regimen in Hepatocellular Carcinoma Using Pretreatment Contrast-Enhanced MRI Based Habitat Analysis and Crossformer Model

Deep learning model based on contrast-enhanced ultrasound for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma

Application of a Convolutional Neural Network for Multitask Learning to Simultaneously Predict Microvascular Invasion and Vessels that Encapsulate Tumor Clusters in Hepatocellular Carcinoma

A Deep Learning Model Combining Multimodal Factors to Predict the Overall Survival of Transarterial Chemoembolization

Predicting Treatment Response from Longitudinal Images Using Multi-Task Deep Learning

Development and Validation of a Deep Learning Model for Survival Prognosis of Transcatheter Arterial Chemoembolization in Patients with Intermediate-Stage Hepatocellular Carcinoma

Deep Learning Radiomics Model of Dynamic Contrast-Enhanced MRI for Evaluating Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma

Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram

Multiparametric MRI‐based model for prediction of local progression of hepatocellular carcinoma after thermal ablation

An Interpretable Machine Learning Model Based on Contrast-Enhanced CT Parameters for Predicting Treatment Response to Conventional Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.

A novel multimodal deep learning model for preoperative prediction of microvascular invasion and outcome in hepatocellular carcinoma

CT-based multimodal deep learning for non-invasive overall survival prediction in advanced hepatocellular carcinoma patients treated with immunotherapy